Date published: 2025-12-22

1-800-457-3801

SCBT Portrait Logo
Seach Input

COH1 Inhibitors

COH1 inhibitors represent a class of chemical compounds specifically designed to target and inhibit the function of the COH1 (Cohesin subunit 1) protein. COH1 is a crucial component of the cohesin complex, a multi-protein structure responsible for mediating the cohesion of sister chromatids during cell division. The cohesin complex plays a vital role in ensuring accurate chromosome segregation, regulating gene expression, and maintaining genome stability. COH1, as a core subunit, is integral to the complex's ability to hold sister chromatids together, particularly from the time of DNA replication until the onset of anaphase in mitosis. Inhibitors of COH1 are designed to interfere with this protein's ability to function properly within the cohesin complex, thereby affecting the overall activity of the complex and altering the processes of chromosomal cohesion and segregation.

The design and development of COH1 inhibitors focus on understanding the structural and functional domains of the COH1 protein, particularly those involved in protein-protein interactions within the cohesin complex. These inhibitors are typically small molecules or peptides that bind specifically to key regions of COH1, such as its ATPase domain or interaction interfaces with other cohesin subunits like SMC1, SMC3, or SCC1. By binding to these critical sites, COH1 inhibitors can disrupt the formation or stability of the cohesin complex, leading to changes in the dynamics of chromosomal cohesion and segregation. The specificity and efficacy of these inhibitors depend on detailed molecular insights into COH1's structure and its interactions with other proteins. Techniques such as X-ray crystallography, cryo-electron microscopy, and molecular docking studies are often employed to identify potential inhibitory compounds and to optimize their binding affinity and selectivity. Through these approaches, COH1 inhibitors are refined to specifically target the cohesin complex's function without affecting other cellular processes, ensuring that the inhibition is precise and effective at modulating COH1 activity.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Valproic Acid

99-66-1sc-213144
10 g
$85.00
9
(1)

Valproic acid, an HDAC inhibitor, may induce hyperacetylation of histone proteins, leading to a relaxed chromatin state and a consequent decrease in COH1 transcription.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$130.00
$270.00
37
(2)

Suberoylanilide Hydroxamic Acid could downregulate COH1 by inhibiting histone deacetylases, which would result in chromatin remodeling and suppression of COH1 promoter activity.

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$65.00
$319.00
$575.00
$998.00
28
(1)

By activating retinoic acid receptors that bind to retinoic acid response elements, retinoic acid may alter transcriptional activity and reduce COH1 mRNA synthesis.

Mithramycin A

18378-89-7sc-200909
1 mg
$54.00
6
(1)

Mithramycin A can bind selectively to the COH1 promoter region, displacing transcription factors and thereby inhibiting the initiation of COH1 transcription.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$214.00
$316.00
$418.00
7
(1)

5-Aza-2′-Deoxycytidine could induce DNA hypomethylation, which may lead to transcriptional silencing of genes upstream of COH1, resulting in reduced expression of the COH1 gene.

Doxorubicin

23214-92-8sc-280681
sc-280681A
1 mg
5 mg
$173.00
$418.00
43
(3)

Doxorubicin intercalates into DNA and could disrupt the transcriptional machinery essential for COH1 gene expression, resulting in decreased levels of COH1 mRNA.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$73.00
$238.00
$717.00
$2522.00
$21420.00
53
(3)

By intercalating into the DNA at the transcription initiation complex, Actinomycin D could inhibit RNA polymerase movement and consequently decrease COH1 mRNA transcription.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

Rapamycin might downregulate COH1 by inhibiting the mTOR signaling pathway, which is involved in the control of protein synthesis and cell cycle progression.

Chloroquine

54-05-7sc-507304
250 mg
$68.00
2
(0)

Chloroquine can inhibit DNA and RNA polymerase activity, potentially leading to a decrease in COH1 gene expression due to disrupted nucleic acid synthesis.

Hydroxyurea

127-07-1sc-29061
sc-29061A
5 g
25 g
$76.00
$255.00
18
(1)

Hydroxyurea's inhibition of ribonucleotide reductase could lead to a shortage of deoxyribonucleotides, which might result in the suppression of COH1 expression.